Skip to main content
SpringerLink
Log in

Conservative management of patients with early endometrial carcinoma: a systematic review

  • Reviews
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Objective

To know the characteristics of endometrial adenocarcinoma in young patients and to review the published experience in patients with endometrial adenocarcinoma that were conservatively managed with hormonal therapy to spare their fertility.

Methods

We carried out a search in the Survey conducted by the Section of Oncologic Gynecology of SEGO (Spanish Society of Gynecologists) to identify the characteristics of young patients with endometrial adenocarcinoma. In addition we searched MEDLINE and other databases for English-language articles describing patients with endometrial adenocarcinoma who were treated with hormonal therapy. The search included articles published between January 1966 and January 2007.

Results

Endometrial carcinoma in patients under 45 years old is an unusual condition that shows a more favourable pattern than in older patients. One hundred and thirty-three patients were found in the search. The average duration of hormonal therapy was approximately six months. The average response time was 12 weeks; 76% of patients treated with hormonal therapy had a complete response and the other 24% never responded to treatment. Of those who initially responded, 66% percent did not show recurrence of disease. The other 34% had a relapse. There have been 4 published deaths of conservatively managed patients.

Conclusion

A conservative approach in these patients can offer reasonable oncological security and the opportunity of fulfilling their maternal desires in selected cases. However, consideration should be taken regarding the potential adverse outcomes that have been recently published in the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. (2004) Cancer facts & figures, 2004. American Cancer Society, Atlanta, GA

  2. Ibáñez E, Chiva L, Rodríguez-Escudero FJ (1999) Resultados de la Encuesta Nacional sobre Carcinoma de Endometrio Diagnosticado en 1993. En Avances en Ginecología Oncológica. Rodríguez-Escudero Eds, Caceres

    Google Scholar 

  3. Herruzo A, Carmona M, Chiva L et al (2003) Evolución de los resultados del tratamiento del cáncer de endometrio en España entre 1980 y 1990. Análisis de las casuísticas nacionales de la sociedad española la de ginecología y obstetricia. Prog Obstet Ginecol 45:54–62

    Google Scholar 

  4. Creasman WT (2002) Adenocarcinoma of the uterus. In: DiSaia PJ, Creasman WT (eds) Clinical gynecologic oncology. St. Louis, MO, Mosby Inc, pp 289–350

    Google Scholar 

  5. Crissman JD, Azoury RS, Barnes AE, Schellhas HF (1981) Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 57:699–704

    PubMed  CAS  Google Scholar 

  6. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP (1998) Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 91:349–354

    Article  PubMed  CAS  Google Scholar 

  7. Bokhman JV, Chepick OF, Volkova AT, Vishnevsky AS (1985) Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 20:139–155

    Article  PubMed  CAS  Google Scholar 

  8. Gallup DG, Stock RJ (1984) Adenocarcinoma of the endometrium in women 40 years of age and younger. Obstet Gynecol 64:417

    PubMed  CAS  Google Scholar 

  9. Patsner B (2000) Endometrial cancer in women 45 years of age or younger. Eur J Gynaecol Oncol 21:249–250

    PubMed  CAS  Google Scholar 

  10. Tran BN, Connell PP, Waggoner S et al (2000) Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol 23:476–480

    PubMed  CAS  Google Scholar 

  11. Fahri DC, Nosanchuk J, Silverberg SG (1986) Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 68:741–745

    Google Scholar 

  12. Gitsch G, Hanzal E, Jensen D, Hacker NF (1995) Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 85:504–508

    Article  PubMed  CAS  Google Scholar 

  13. Lee NK, Cheung MK, Shin JY et al (2007) Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 109:655–662

    PubMed  Google Scholar 

  14. Walsh C, Holschneider C, Hoang Y et al (2005) Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 106:693–699

    PubMed  Google Scholar 

  15. Kendall BS, Ronnett BM, Isacson C et al (1998) Reproducibility of the diagnosis of endometrial hyperplasia, AH, and well-differentiated carcinoma. Am J Surg Pathol 22:1012–1019

    Article  PubMed  CAS  Google Scholar 

  16. Ehrlich CE, Young PC, Stehman FB et al (1988) Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 158:796–807

    PubMed  CAS  Google Scholar 

  17. Pace S, Grassi A, Ferrero S et al (1995) Diagnostic methods of early detection of endometrial hyperplasia and cancer. Eur J Gynaecol Oncol 16:373–381

    PubMed  CAS  Google Scholar 

  18. Bergeron C, Nogales FF, Masseroli M et al (1999) A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 23:1102–1108

    Article  PubMed  CAS  Google Scholar 

  19. Mutter GL and the Endometrial Collaborative Group (2000) Endometrial Intraepithelial Neoplasia (EIN): will it bring order to chaos? Gynecol Oncol 76:287–290

    Article  PubMed  CAS  Google Scholar 

  20. Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 56:403–412

    Article  PubMed  CAS  Google Scholar 

  21. Baak JPA, Wisse-Brekelmans ECM, Fleege JC et al (1992) Assessment of the risk of endometrial cancer in hyperplasia by means of morphological and morphometrical features. Path Res Pract 188:856–859

    PubMed  CAS  Google Scholar 

  22. Larson DM, Johnson KK, Broste SK et al (1995) Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 86:38–42

    Article  PubMed  CAS  Google Scholar 

  23. Kinkel K, Kaji Y, Yu KK et al (1999) Radiologic staging in patients with endometrial cancer: a metaanalysis. Radiology 212:711–718

    PubMed  CAS  Google Scholar 

  24. Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:850–855

    Article  PubMed  CAS  Google Scholar 

  25. Taieb S, Ceugnart L, Leblanc E et al (2002) MR imaging of endometrial carcinoma: role and limits. Bull Cancer 89:963–968

    PubMed  Google Scholar 

  26. Yoshida Y, Kurokawa T, Yagihara R, Kotsuji F (2006) The usefulness of FES-PET for the prediction of the therapeutic effect of hormonal therapy in a patient with endometrial cancer — a case report (abstract). J Obstet Gynaecol Res 58:406

    Google Scholar 

  27. Yahata T, Fujita K, Aoki Y, Tanaka K (2006) Long-term conservative therapy for endometrial adenocarcinoma in young women. Hum Reprod 21:1070–1075

    Article  PubMed  CAS  Google Scholar 

  28. Ushijima K, Yahata H, Yoshikawa H et al (2007) Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25:2798–2803

    Article  PubMed  CAS  Google Scholar 

  29. Varga A, Henriksen E (1961) Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometrial carcinoma. Obstet Gynecol 18:658–672

    PubMed  CAS  Google Scholar 

  30. Montz FJ, Bristow RE, Bovicelli A et al (2002) Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 186:651–657

    Article  PubMed  CAS  Google Scholar 

  31. Šparac V, Ujevi? B, Ujevi? M et al (2006) Successful pregnancy after hysteroscopic removal of grade I endometrial carcinoma in a young woman with Lynch syndrome. Int J Gynecol Cancer 16[Suppl 1]:442–445

    PubMed  Google Scholar 

  32. Vilos GD, Ettler HC, Edris F et al (2007) Endometrioid adenocarcinoma treated by hysteroscopic endomyometrial resection. J Min Inv Gyn 14:119–122

    Article  Google Scholar 

  33. Emons G, Heyl W (2000) Hormonal treatment of endometrial cancer. J Cancer Res Clin Oncol 126:619–623

    Article  PubMed  CAS  Google Scholar 

  34. Gallagher CJ, Oliver RT, Ohram DH (1991) A new treatment for endometrial cancer with gonadotropin-releasing hormone analogue. Br J Obstet Gynaecol 98:1037–1041

    PubMed  CAS  Google Scholar 

  35. De Vriese G, Bonte J (1993) Possible role of goserelin, an LH-RH agonist in the treatment of gynaecological cancers. Eur J Gynaecol Oncol 14:187–191

    PubMed  Google Scholar 

  36. Agorastos T, Bontis J, Vakiani A et al (1997) Treatment of endometrial hyperplasias with gonadotrophin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data. Gynecol Oncol 65:102–114

    Article  PubMed  CAS  Google Scholar 

  37. Kullander S (1992) Treatment of endometrial cancer with GnRH analogues. Recent Result Cancer Res 124:69–73

    CAS  Google Scholar 

  38. Saegusa M, Okayasu I (1998) Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. Cancer 83:111–121

    Article  PubMed  CAS  Google Scholar 

  39. Emons G, Schröder B, Ortmann O et al (1993) High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab 77:1458–1464

    Article  PubMed  CAS  Google Scholar 

  40. Deligdisch L (1993) Effects of hormone therapy on the endometrium. Mod Pathol 6:94–106

    PubMed  CAS  Google Scholar 

  41. Podratz KC, O’Brien PC, Malkasian GD Jr et al (1985) Effects of progestational agents in treatment of endometrial carcinoma. Obstet Gynecol 66:106–110

    PubMed  CAS  Google Scholar 

  42. Ramirez PT, Frumovitz M, Bodurka DC et al (2004) Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 95:133–138

    Article  PubMed  CAS  Google Scholar 

  43. Yazbeck C, Dhainaut C, Thoury A et al (2005) Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG 112:317–320

    Article  Google Scholar 

  44. Nakao Y, Nomiyama M, Kojima K et al (2004) Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma. Gynecol Obstet Invest 58:68–71

    Article  PubMed  Google Scholar 

  45. Yarali H, Bozdag G, Aksu T, Ayhan A (2004) A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively. Fertil Steril 81:214–216

    Article  PubMed  Google Scholar 

  46. Paulson RJ, Sauer MV, Lobo RA (1990) Pregnancy after in vitro fertilization in a patient with stage I endometrial carcinoma treated with progestins. Fertil Steril 54:735–736

    PubMed  CAS  Google Scholar 

  47. Niwa K, Yokoyama Y, Tanaka T et al (1994) Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. Arch Gynecol Obstet 255:91–94

    Article  PubMed  CAS  Google Scholar 

  48. Kimmig R, Strowitzki T, Muller-Hocker J et al (1995) Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 58:255–257

    Article  PubMed  CAS  Google Scholar 

  49. Kim YB, Holschneider CH, Ghosh K et al (1997) Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 79:320–327

    Article  PubMed  CAS  Google Scholar 

  50. Randall TC, Kurman RJ (1997) Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90:434–440

    Article  PubMed  CAS  Google Scholar 

  51. Niwa K, Morishita S, Hashimoto M et al (1997) Conservative therapy for endometrial carcinoma in young women treated with repeated curettage and progestogen. Int J Clin Oncol 2:165–169

    Article  Google Scholar 

  52. Zanetta G, Gabriele A, Losa G et al (1997) Conservative management of endometrial carcinoma with prolonged preservation of the uterus in a young patient. Int J Gynecol Cancer 7:332–334

    Article  Google Scholar 

  53. Vinker S, Shani A, Open M et al (1999) Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate? Eur J Obstet Gynecol Reprod Biol 83:63–65

    Article  PubMed  CAS  Google Scholar 

  54. Sardi J, Anchezar Henry JP, Paniceres G et al (1998) Primary hormonal treatment for early endometrial carcinoma. Eur J Gynaecol Oncol 19: 565–568

    PubMed  CAS  Google Scholar 

  55. Schammel DP, Mittal KR, Kaplan K et al (1998) Endometrial adenocarcinoma associated with intrauterine pregnancy. A report of five cases and a review of the literature. Int J Gynecol Pathol 17:327–335

    Article  PubMed  CAS  Google Scholar 

  56. Kowalczyk CL, Malone J Jr, Peterson EP et al (1999) Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception. A case report. J Reprod Med 44:57–60

    PubMed  CAS  Google Scholar 

  57. Jobo T, Imai M, Kawaguchi M et al (2000) Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases. Eur J Gynecol Oncol 21:119–122

    CAS  Google Scholar 

  58. Mitsushita J, Toki T, Kato K et al (2000) Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxy progesterone acetate. Gynecol Oncol 79:129–132

    Article  PubMed  CAS  Google Scholar 

  59. Imai M, Jobo T, Sato R et al (2001) Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus — usefulness and limitations. Eur J Gynaecol Oncol 22:217–220

    PubMed  CAS  Google Scholar 

  60. Kaku T, Yoshikawa H, Tsuda H et al (2001) Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 167:39–48

    Article  PubMed  CAS  Google Scholar 

  61. Wang CB, Wang CJ, Huang HJ et al (2002) Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 94:2192–2198

    Article  PubMed  Google Scholar 

  62. Shibahara H, Shigeta M, Toji H et al (1999) Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection. Hum Reprod 14:1908–1911

    Article  PubMed  CAS  Google Scholar 

  63. O’Neill RT (1970) Pregnancy following hormonal therapy for adenocarcinoma of the endometrium. Am J Obstet Gynecol 108:318–321

    PubMed  CAS  Google Scholar 

  64. Muechler EK, Bonfiglio T, Choate J, Huang KE (1986) Pregnancy induced with menotropins in a woman with polycystic ovaries, endometrial hyperplasia, and adenocarcinoma. Fertil Steril 46:973–975

    PubMed  CAS  Google Scholar 

  65. Paulson RJ, Sauer MV, Lobo RA (1990) Pregnancy after in vitro fertilization in a patient with stage I endometrial carcinoma treated with progestins. Fertil Steril 54:735–736

    PubMed  CAS  Google Scholar 

  66. Lai CH, Hsueh S, Chao AS, Soong YK (1994) Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma. Br J Obstet Gynaecol 101:547–549

    PubMed  CAS  Google Scholar 

  67. Niwa K, Yokoyama Y, Tanaka T et al (1994) Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. Arch Gynecol Obstet 255:91–94

    Article  PubMed  CAS  Google Scholar 

  68. Kimmig R, Strowitzki T, Müller-Höcker J et al (1995) Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 58:255–257

    Article  PubMed  CAS  Google Scholar 

  69. Kowalczyk CL, Malone J, Peterson EP et al (1999) Well differentiated endometrial adenocarcinoma in an infertility patient with later conception. J Reprod Med 44:57–60

    PubMed  CAS  Google Scholar 

  70. Mitsushita J, Toshihiko T, Kato K et al (2000) Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecol Oncol 79:129–132

    Article  PubMed  CAS  Google Scholar 

  71. Pinto AB, Gopal MG, Herzog TJ et al (2001) Successful in vitro fertilization pregnancy after conservative management of endometrial cancer. Fertil Steril 76:826–829

    Article  PubMed  CAS  Google Scholar 

  72. Lowe MP, Bender D, Sood AK et al (2002) Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction. Fertil Steril 77:188–189

    Article  PubMed  Google Scholar 

  73. Zuckerman B, Lavie O, Neuman M et al (1998) Endometrial stage I-grade II. Conservative treatment followed by a healthy twin pregnancy. Int J Gynecol Cancer 8:172–174

    Article  Google Scholar 

  74. Huang SY, Jung SM, Ng KK et al (2005) Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment. Gynecol Oncol 97:652–655

    Article  PubMed  CAS  Google Scholar 

  75. Yasuda M, Matsui N, Kajiwara H et al (2004) Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation. Pathol Int 54:451–456

    Article  PubMed  Google Scholar 

  76. Ferrandina G, Zannoni GF, Gallotta V et al (2005) Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report. Gynecol Oncol 99:215–217

    Article  PubMed  CAS  Google Scholar 

  77. Ota T, Yoshida M, Kimura M, Kinoshita K (2005) Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Int J Gynecol Cancer 15:657–662

    Article  PubMed  CAS  Google Scholar 

  78. Cormio G, Martino R, Loizzi V et al (2006) A rare case of choroidal metastasis presented after conservative management of endometrial cancer. Int J Gynecol Cancer 16:2044–2048

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Ginecología Oncológica, MD Anderson International, C/ Gómez Hemans, 4, ES-28033, Madrid, Spain

    Luis Chiva de Agustín, Fernando Lapuente Sastre, Virginia Corraliza Galán, Luis Granados Galainena, Antonio González Martín, Lucía González Cortijo & Natalia Carballo González

Authors
  1. Luis Chiva de Agustín
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernando Lapuente Sastre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Virginia Corraliza Galán
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luis Granados Galainena
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio González Martín
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lucía González Cortijo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Natalia Carballo González
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luis Chiva de Agustín.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agustín, L.C.d., Sastre, F.L., Galán, V.C. et al. Conservative management of patients with early endometrial carcinoma: a systematic review. Clin Transl Oncol 10, 155–162 (2008). https://doi.org/10.1007/s12094-008-0173-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-008-0173-1

Keywords

Search

Navigation